222854-87-7

Basic information

• Product Name: 1,3,5,2,4-Trioxadisilocino7,6-bpyrrole-7(6H)-carboxylic acid, 8-(4,5-dihydro-4-oxo-1H-pyrrolo3,2-dpyrimidin-7-yl)tetrahydro-2,2,4,4-tetrakis(1-methylethyl)-, 1,1-dimethylethyl ester, (6aR,8R,9aS)-
• Synonyms: 1,3,5,2,4-Trioxadisilocino7,6-bpyrrole-7(6H)-carboxylic acid, 8-(4,5-dihydro-4-oxo-1H-pyrrolo3,2-dpyrimidin-7-yl)tetrahydro-2,2,4,4-tetrakis(1-methylethyl)-, 1,1-dimethylethyl ester, (6aR,8R,9aS)-
• CAS NO: 222854-87-7
• Molecular Formula: C28H48 N4 O6 Si2
• Molecular Weight: 592.87
• Mol File: 222854-87-7.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3,5,2,4-Trioxadisilocino7,6-bpyrrole-7(6H)-carboxylic acid, 8-(4,5-dihydro-4-oxo-1H-pyrrolo3,2-dpyrimidin-7-yl)tetrahydro-2,2,4,4-tetrakis(1-methylethyl)-, 1,1-dimethylethyl ester, (6aR,8R,9aS)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,5,2,4-Trioxadisilocino7,6-bpyrrole-7(6H)-carboxylic acid, 8-(4,5-dihydro-4-oxo-1H-pyrrolo3,2-dpyrimidin-7-yl)tetrahydro-2,2,4,4-tetrakis(1-methylethyl)-, 1,1-dimethylethyl ester, (6aR,8R,9aS)-(222854-87-7)
• EPA Substance Registry System: 1,3,5,2,4-Trioxadisilocino7,6-bpyrrole-7(6H)-carboxylic acid, 8-(4,5-dihydro-4-oxo-1H-pyrrolo3,2-dpyrimidin-7-yl)tetrahydro-2,2,4,4-tetrakis(1-methylethyl)-, 1,1-dimethylethyl ester, (6aR,8R,9aS)-(222854-87-7)

Safety Data

• Hazardous Substances Data: 222854-87-7(Hazardous Substances Data)

Usage

Molecular structure

The compound has a complex molecular structure consisting of multiple functional groups and atoms.

Functional groups

The compound contains various functional groups, including carboxylic acid, pyrrole, pyrimidine, and ester groups.

Stereochemistry

The compound has specific stereochemistry, with the (6aR,8R,9aS) configuration.

Molecular weight

The molecular weight of the compound is approximately 593.77 g/mol.

Solubility

The compound may have varying solubility in different solvents, depending on the functional groups present.

Reactivity

The compound may exhibit different reactivity due to the presence of multiple functional groups and the specific arrangement of atoms.

Potential applications

The compound may have potential applications in various fields, such as pharmaceuticals, materials science, and organic chemistry.

Synthesis

The synthesis of this complex compound likely involves multiple steps and the use of various reagents and reaction conditions.

Stability

The stability of the compound may depend on factors such as temperature, pH, and the presence of other chemicals.

Structural analysis

Techniques such as X-ray crystallography, NMR spectroscopy, and mass spectrometry may be used to analyze the structure and properties of the compound.

Biological activity

The compound may have potential biological activity, which could be investigated through in vitro and in vivo studies.

Toxicity

The toxicity of the compound is not known and would need to be evaluated through appropriate testing methods.

Environmental impact

The environmental impact of the compound is not known and would need to be assessed through ecological risk assessments.

Regulatory status

The regulatory status of the compound may vary depending on its intended use and the specific regulations in different countries or regions.

Upstream product

• 222854-85-5 (2R,3aS,9aR)-2-[(Z)-1-Cyano-2-(ethoxycarbonylmethyl-amino)-vinyl]-5,5,7,7-tetraisopropyl-tetrahydro-4,6,8-trioxa-1-aza-5,7-disila-cyclopentacyclooctene-1-carboxylic acid tert-butyl ester 
• 222854-82-2 N-tert-butoxycarbonyl-2,3,6-trideoxy-4-O-[imidazole-(thiocarbonyl)]-3,6-imino-5,7-O-(1,1,3,3-tetraisopropyldisiloxa-1,3-diyl)-D-allo-heptononitrile 
• 284490-18-2 (2R,3aS,9aR)-2-((Z)-1-Cyano-2-hydroxy-vinyl)-5,5,7,7-tetraisopropyl-tetrahydro-4,6,8-trioxa-1-aza-5,7-disila-cyclopentacyclooctene-1-carboxylic acid tert-butyl ester 
• 222854-81-1 N-tert-butoxycarbonyl-2,3,6-trideoxy-3,6-imino-5,7-O-(1,1,3,3-tetraisopropyldisiloxa-1,3-diyl)-D-allo-heptononitrile 
• 222854-83-3 N-tert-butoxycarbonyl-2,3,4,6-tetradeoxy-3,6-imino-5,7-O-(1,1,3,3-tetraisopropyldisiloxa-1,3-diyl)-D-ribo-heptononitrile 
• 222631-08-5 2-((3aS,4S,6R,6aR)-6-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo [4,5-c]pyrrol-4-yl)acetonitrile 
• 222631-23-4 N-tert-butoxycarbonyl-2,3,6-trideoxy-3,6-imino-D-allo-heptononitrile 
• 222631-20-1 2,3,6-trideoxy-3,6-imino-D-allo-heptononitrile 
• 153172-33-9 (3aR,4R,6aS)-4-(((tert-butyldimethylsilyl)oxy)methyl)-2,2-dimethyl-4,6a-dihydro-3aH-[1,3]dioxolo[4,5-c]pyrrole 
• 153172-31-7 (3aR,4R,6aS)-4-({[(tert-butyl)(dimethyl)silyl]oxy}methyl)tetrahydro-2,2-dimethyl-3aH-[1,3]dioxolo[4,5-c]pyrrole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 3473-63-0 formamidine acetic acid 
• 222854-86-6 (1R)-1-[3-amino-1-N-benzyloxycarbonyl-2-ethoxycarbonylpyrrol-4-yl]-N-tert-butoxycarbonyl-1,2,4-trideoxy-1,4-imino-3,5-O-(1,1,3,3-tetraisopropyldisiloxa-1,3-diyl)-D-erythro-pentitol 

Relevant articles and documents

Synthesis of transition state analogue inhibitors for purine nucleoside phosphorylase and N-riboside hydrolases

Syntheses of the 'Immucillins', potent aza-C-nucleoside inhibitors of purine nucleoside phosphorylase are reported as well as those of 5-deoxy-, 5- deoxyfluoro- and 2-deoxy- analogues and others having modified bases. (C) 2000 Elsevier Science Ltd.